What causes Alzheimer’s, Parkinson’s and other neurodegenerative diseases? Meet the biomarkers (aka Prions or misfolded proteins) that are driving these diseases.
Over the past 100 years, we have been flying blind in drug development for Alzheimer’s and Parkinson’s. Despite spending over $100 billion dollars in drug development and clinical trials, there is not a single drug that passes FDA approval so far.
Why has there been no effective treatment for Alzheimer’s and Parkinson’s?
The culprit: lack of early detection of the biomarkers that cause the disease. Without early detection, there is no effective way to develop treatments. Until now… for the first time in history, Amprion is changing the game on Alzheimer’s and Parkinson’s.
Our breakthrough Prion Early Detection Science℠ offers accurate tracking of the three biomarkers that cause the disease prior to any clinical symptoms. We believe early detection is the only pathway that leads to successful development of effective treatments based on personal biomarker profiles.
Related Posts on Early Prion Detection:
- The Amprion Story | Early Detection for Alzheimer’s & Parkinson’s
- Early Detection is Key to Preventive Brain Care
- Early Detection of Biomarkers For Alzheimer’s and Parkinson’s
- Sensitive & Early Biochemical Diagnosis of Alzheimer’s Disease